Arvinas Inc. has announced new compensation terms for Dr. Teel, who has been appointed under an amended and restated employment agreement. Dr. Teel will receive an annual base salary of $680,000 and will be eligible for a performance-based annual cash bonus target of 60% of his base salary. Additionally, Dr. Teel will be granted a stock option to purchase 218,691 shares of common stock and a restricted stock unit award for 147,179 shares, both vesting over four years. In the event of termination without cause or resignation for good reason within 12 months following a change in control, Dr. Teel will be entitled to 18 months of continued base salary, continued health coverage premiums for up to 18 months, a lump sum payment equal to 150% of his target bonus, and full acceleration of unvested equity awards.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arvinas Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-007463), on February 12, 2026, and is solely responsible for the information contained therein.